On December 19, 2023 Medigene AG (Medigene or the "Company", FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid tumors, reported that it will be attending the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco to be held from January 8-11, 2024 (Press release, MediGene, DEC 19, 2023, View Source [SID1234638690]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
J.P. Morgan Healthcare Conference
View Source
Date: January 8-11, 2024
Location: The Westin St. Francis Hotel, San Francisco, CA
Members of Medigene’s management team will be available for one-on-one meetings to showcase the Company’s unique scientific platform, product pipeline, execution of its corporate strategy, and 2024 plans. Please contact Pamela Keck at [email protected] to schedule a meeting.